Renaissance Technologies
BOLT icon

Renaissance Technologies’s Bolt Biotherapeutics BOLT Stock Holding History

Renaissance Technologies’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
98,625
+21,400
+28% +$100K ﹤0.01% 2705
2026
Q1 		$312K Buy
77,225
+22,200
+40% +$116K ﹤0.01% 2778
2025
Q4 		$301K Buy
55,025
+26,400
+92% +$142K ﹤0.01% 2760
2025
Q3 		$152K Buy
28,625
+10,300
+56% +$57.1K ﹤0.01% 3189
2025
Q2 		$106K Buy
18,325
+2,618
+17% +$17.3K ﹤0.01% 3292
2025
Q1 		$126K Buy
15,707
+605
+4% +$5.81K ﹤0.01% 3156
2024
Q4 		$162K Buy
15,102
+400
+3% +$4.84K ﹤0.01% 3217
2024
Q3 		$191K Buy
14,702
+865
+6% +$11.9K ﹤0.01% 3138
2024
Q2 		$208K Sell
13,837
-12,045
-47% -$238K ﹤0.01% 3036
2024
Q1 		$725K Buy
25,882
+3,618
+16% +$83.8K ﹤0.01% 2679
2023
Q4 		$499K Buy
22,264
+6,555
+42% +$128K ﹤0.01% 2778
2023
Q3 		$327K Sell
15,709
-8,488
-35% -$207K ﹤0.01% 2888
2023
Q2 		$619K Buy
24,197
+1,360
+6% +$43.2K ﹤0.01% 2751
2023
Q1 		$635K Buy
22,837
+760
+3% +$22.2K ﹤0.01% 2755
2022
Q4 		$574K Buy
22,077
+2,384
+12% +$65.3K ﹤0.01% 2875
2022
Q3 		$583K Sell
19,693
-7,236
-27% -$299K ﹤0.01% 2838
2022
Q2 		$1.1M Buy
26,929
+12,424
+86% +$482K ﹤0.01% 2647
2022
Q1 		$795K Buy
14,505
+10,060
+226% +$677K ﹤0.01% 2876
2021
Q4 		$436K Buy
4,445
+480
+12% +$91.1K ﹤0.01% 3142
2021
Q3 		$1M Buy
3,965
+941
+31% +$266K ﹤0.01% 2546
2021
Q2 		$935K Buy
+3,024
New +$1.23M ﹤0.01% 2697

Other funds holding BOLT

TC
T3 Companies New York $93.7M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies's BOLT Position: Q2 2026 in Review

Renaissance Technologies increased its Bolt Biotherapeutics (BOLT) stake by 28% in Q2 2026, buying an estimated $100K and bringing the position to 98,625 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #2705.

Renaissance Technologies first reported a position in BOLT in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.1M in Q2 2022. 19 funds tracked by Wall St. Rank hold BOLT as of Q2 2026.

  • Renaissance Technologies held 98,625 shares of Bolt Biotherapeutics worth $380K as of Q2 2026.
  • Renaissance Technologies bought 21,400 Bolt Biotherapeutics shares in Q2 2026, an estimated $100K.
  • Bolt Biotherapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2705 holding.
  • Renaissance Technologies first reported a position in Bolt Biotherapeutics in Q2 2021 and has held it in 21 quarters since.
  • Renaissance Technologies's Bolt Biotherapeutics position peaked at $1.1M in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.